cyclopentane has been researched along with Chronic Lung Injury in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Charles, EJ; Huerter, ME; Johnston, WF; Kron, IL; Laubach, VE; Lynch, KR; Sharma, AK; Stone, ML; Zhao, Y | 1 |
1 other study(ies) available for cyclopentane and Chronic Lung Injury
Article | Year |
---|---|
Sphingosine-1-phosphate receptor 1 agonism attenuates lung ischemia-reperfusion injury.
Topics: Animals; Bronchoalveolar Lavage Fluid; Cyclopentanes; Cytokines; Fingolimod Hydrochloride; Flow Cytometry; Immunoenzyme Techniques; Immunosuppressive Agents; Lung Injury; Lysophospholipids; Mice; Mice, Inbred C57BL; Propylene Glycols; Receptors, Lysosphingolipid; Reperfusion Injury; Sphingosine; Sphingosine-1-Phosphate Receptors | 2015 |